Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Castle Creek Biosciences, Inc. See All Filings	D	2025-02-25 16:24:15 UTC
Amount To Be Raised $75,000,000 Associated Brokers / Dealers Paragon Health Capital, LLC CIK Number 0001756702 Filed Document 0001756702-25-000001 Exclusions or Exemptions 506b Accepted Date 2025-02-25 16:24:15 UTC Type of Offering D Industry Biotechnology Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Castle Creek Biosciences, Inc. See All Filings	D	2022-05-02 13:44:15 UTC
Amount To Be Raised $112,782,892 Associated Brokers / Dealers Paragon Health Capital, LLC CIK Number 0001756702 Filed Document 0001756702-22-000002 Exclusions or Exemptions 506b Accepted Date 2022-05-02 13:44:15 UTC Type of Offering D Industry Biotechnology Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
Castle Creek Biosciences, Inc. See All Filings	D	2022-02-03 14:49:58 UTC
Amount To Be Raised $11,850,000 Associated Brokers / Dealers Paragon Health Capital, LLC CIK Number 0001756702 Filed Document 0001756702-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-02-03 14:49:58 UTC Type of Offering D Industry Biotechnology Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Debt
Castle Creek Pharmaceutical Holdings, Inc. See All Filings	D	2020-01-21 17:05:53 UTC
Amount To Be Raised $54,602,249 Associated Brokers / Dealers Paragon Health Capital, LLC CIK Number 0001756702 Filed Document 0001756702-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-01-21 17:05:53 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
Castle Creek Pharmaceutical Holdings, Inc. See All Filings	D	2018-10-24 14:37:02 UTC
Amount To Be Raised $560,544,226 Associated Brokers / Dealers Octagon Capital Group, LLC CIK Number 0001756702 Filed Document 0001756702-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-10-24 14:37:02 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity